evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large b-cell lymphoma patients after previous treatment with rituximab and chemotherapy results of the pro-..
本文档由 wug266006 分享于2017-04-22 00:10
evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large b-cell lymphoma patients after previous treatment with rituximab and chemotherapy results of the pro-r-ipi study
下载文档
收藏
打印
分享：
君，已阅读到文档的结尾了呢~~